← Back to Search

Behavioural Intervention

Meditation for Cancer Survivors

N/A
Recruiting
Led By Richard T Lee
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: ≥ 18 years
No previous training in mind-body relaxation techniques exceeding 3 hours or regular practice within the past 12 months
Must not have
Previous serious illnesses affecting neurological functioning such as strokes, heart attacks, Parkinson disease, etc
Active cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights

Summary

This trial is testing different meditation techniques to see which one is most effective in helping cancer survivors relax and reduce stress and anxiety. Meditation involves methods like breathing, focusing attention, and mindfulness to improve the overall

Who is the study for?
This trial is for cancer survivors who are looking to reduce stress and anxiety through meditation. Participants will try one of four meditation practices to see which helps them relax the most.
What is being tested?
The study tests four types of meditation: breathing, focused attention, mindfulness, and a combination of all three. The goal is to determine which method best promotes relaxation and improves quality of life in cancer survivors.
What are the potential side effects?
Meditation therapy is generally considered safe with minimal risks. Some participants may experience increased anxiety or discomfort during practice, but serious side effects are rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I haven't practiced mind-body relaxation for more than 3 hours or regularly in the last year.
Select...
I can fluently speak and understand English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not had serious illnesses like strokes or heart disease affecting my brain.
Select...
My cancer is currently active.
Select...
I am currently pregnant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rate
Retention rate

Trial Design

4Treatment groups
Experimental Treatment
Group I: Arm IV (combined meditation)Experimental Treatment3 Interventions
Patients learn breathing, focused attention, and mindfulness combined meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.
Group II: Arm III (mindfulness only meditation)Experimental Treatment3 Interventions
Patients learn mindfulness only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.
Group III: Arm I (focused attention only meditation)Experimental Treatment3 Interventions
Patients learn focused attention only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.
Group IV: Arm I (breathing only meditation)Experimental Treatment3 Interventions
Patients learn breathing only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020
Meditation Therapy
2018
N/A
~50

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
596 Previous Clinical Trials
1,923,493 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,956 Total Patients Enrolled
Richard T LeePrincipal InvestigatorCity of Hope Medical Center
1 Previous Clinical Trials
~29 spots leftby Jun 2026